Detalles de la búsqueda
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
2.
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
Oncologist
; 29(5): e690-e698, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38377176
3.
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?
Expert Opin Emerg Drugs
; 28(2): 121-127, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37144331
4.
Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes.
Int J Mol Sci
; 24(3)2023 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36768754
5.
New approach to implement cancer patient care: The valutazione percorso rete oncologica campana (ValPeROC)-experience from an Italian oncology network.
Eur J Cancer Care (Engl)
; 31(6): e13736, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37039607
6.
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.
Int J Mol Sci
; 23(15)2022 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35955681
7.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2027-2039, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280657
8.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
BMC Cancer
; 21(1): 549, 2021 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985435
9.
First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly.
Curr Oncol Rep
; 23(10): 119, 2021 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34342732
10.
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial.
Br J Cancer
; 122(10): 1461-1466, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32210365
11.
New immunotherapy in the treatment of advanced renal cancer.
Expert Opin Emerg Drugs
; 24(4): 233-237, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31751164
12.
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial.
Eur J Nucl Med Mol Imaging
; 45(11): 1908-1914, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730697
13.
Evolution in the treatment landscape of non-small cell lung cancer with ALK gene alterations: from the first- to third-generation of ALK inhibitors.
Expert Opin Emerg Drugs
; 23(3): 231-241, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30251885
14.
Ceritinib versus chemotherapy in patients with ALK-rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 18(7): 874-886, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28602779
15.
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.
Anticancer Drugs
; 28(1): 104-109, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27579728
16.
An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma.
Expert Opin Emerg Drugs
; 22(3): 213-222, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836854
17.
Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.
Support Care Cancer
; 25(1): 85-92, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27557833
18.
Novel cytotoxic drugs in advanced nonsmall cell lung cancer.
Curr Opin Oncol
; 28(2): 110-4, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26742018
19.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 16(9): 1071-1078, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272768
20.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Lancet Oncol
; 16(9): 1079-1089, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272769